Cargando…
Crosstalk between Ca(2+) Signaling and Cancer Stemness: The Link to Cisplatin Resistance
In the fight against cancer, therapeutic strategies using cisplatin are severely limited by the appearance of a resistant phenotype. While cisplatin is usually efficient at the beginning of the treatment, several patients endure resistance to this agent and face relapse. One of the reasons for this...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503744/ https://www.ncbi.nlm.nih.gov/pubmed/36142596 http://dx.doi.org/10.3390/ijms231810687 |